[EN] NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS<br/>[FR] NOUVEAUX INHIBITEURS À PETITES MOLÉCULES DE FACTEURS DE TRANSCRIPTION TEAD
申请人:MASSACHUSETTS GEN HOSPITAL
公开号:WO2020190774A1
公开(公告)日:2020-09-24
The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.
SYNTHESIS AND EVALUATION OF ANTI-HSV ACTIVITY OF NEW 5-ALKYNYL-2′-DEOXYURIDINES
作者:A. A. Pchelintseva、M. V. Skorobogatyj、A. L. Petrunina、V. L. Andronova、G. A. Galegov、I. V. Astakhova、A. V. Ustinov、A. D. Malakhov、Vladimir A. Korshun
DOI:10.1081/ncn-200059280
日期:2005.4.1
Eight 5-alkynyl-2'deoxyuridines containing different bulky substituents have been prepared and tested against HSV-1 in Vero cells. The compounds show positive antiviral activity. There is no obvious correlation between activity and substituent size. The nature of the linker between uracil and a substituent appears to be more important for antiviral properties: nucleosides containing arylethynyl groups show higher activity.